Sight Sciences Ownership
| SGHT Stock | USD 3.98 0.03 0.75% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Sight |
Sight Stock Ownership Analysis
About 20.0% of the company outstanding shares are owned by corporate insiders. The book value of Sight Sciences was at this time reported as 1.88. The company recorded a loss per share of 1.01. Sight Sciences had not issued any dividends in recent years. Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company was incorporated in 2010 and is headquartered in Menlo Park, California. Sight Sciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 212 people. To find out more about Sight Sciences contact the company at 877 266 1144 or learn more at https://www.sightsciences.com.Besides selling stocks to institutional investors, Sight Sciences also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Sight Sciences' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Sight Sciences' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Sight Sciences Quarterly Liabilities And Stockholders Equity |
|
Sight Sciences Insider Trades History
About 20.0% of Sight Sciences are currently held by insiders. Unlike Sight Sciences' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Sight Sciences' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Sight Sciences' insider trades
Sight Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sight Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sight Sciences backward and forwards among themselves. Sight Sciences' institutional investor refers to the entity that pools money to purchase Sight Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-09-30 | 325.8 K | D. E. Shaw & Co Lp | 2024-09-30 | 321.6 K | Millennium Management Llc | 2024-06-30 | 296.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 257 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 207.9 K | Panagora Asset Management Inc | 2024-09-30 | 194.8 K | National Asset Management Inc | 2024-06-30 | 185.1 K | Millrace Asset Group, Inc | 2024-09-30 | 138.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 136 K | Bank Of America Corp | 2024-06-30 | 3.1 M | Ubs Group Ag | 2024-06-30 | 2.9 M |
Sight Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sight Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sight Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sight Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sight Sciences Outstanding Bonds
Sight Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sight Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sight bonds can be classified according to their maturity, which is the date when Sight Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| SIERRA 6 15 JUN 28 Corp BondUS82653LAA98 | View |
Sight Sciences Corporate Filings
F4 | 21st of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 5th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.